Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €122.80 EUR
Change Today -1.35 / -1.09%
Volume 193.0K
SOLB On Other Exchanges
EN Brussels
As of 11:35 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

solvay sa (SOLB) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/10/15 - €141.10
52 Week Low
01/6/15 - €104.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SOLVAY SA (SOLB)

Related News

No related news articles were found.

solvay sa (SOLB) Related Businessweek News

No Related Businessweek News Found

solvay sa (SOLB) Details

Solvay SA engages in the chemical and plastic businesses worldwide. It operates in five segments: Advanced Formulations, Advanced Materials, Performance Chemicals, Functional Polymers, and Corporate & Business Services. The company offers chemical products, such as advanced materials, barium and strontium, calcium chloride, caustic soda, chlorinated products, fluor, peroxygen products, polyglycerols, precipitated calcium carbonate, soda ash, and sodium bicarbonate. It also provides specialty polymers, such as biomaterials for implantable devices, cross-linkable compounds, films, fluorinated elastomers, fluorinated fluids, fluoropolymers, functional fluids, liquid crystal polymers, polyamide-imides, aromatic polyamides, polyesters, polyketones, aromatic polymer processing aids, polyphenylene, polyphenylene sulfide, polyvinylidene chloride, specialty materials, and sulfone polymers; and vinyls comprising Benvic plasticized PVC compounds, Benvic PVC alloys, Benvic rigid PVC compounds, Nidacell, SolVin copolymers, SolVin general purpose, SolVin specialties, and Vinyloop regenerated PVC. In addition, the company offers cellulose acetate tow; diphenols/aliphatic fluorinated derivatives specialties; chlorinated products, such as allyls and chloromethanes; oxygenated solvents; phenol-based products and derivatives; chlor - alkali derivatives; polyamide-based fibers; hydrogen peroxide; polyamide and intermediates; rare earth-based formulations; dispersible silica; specialty surfactants; and engineering plastics, textile, industrial fibers and yarns, varnishes, and adhesives. Further, it provides energy optimization services; and carbon management services and clean technologies. The company’s products are used in consumer goods and healthcare; automotive and aeronautics; building and construction; electrical and electronics; agro, feed, and food; energy and environment; and industrial applications. Solvay SA was founded in 1863 and is headquartered in Brussels, Belgium.

26,000 Employees
Last Reported Date: 05/6/15
Founded in 1863

solvay sa (SOLB) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: €2.5M
Compensation as of Fiscal Year 2014.

solvay sa (SOLB) Key Developments

Solvay and INEOS Announce Joint Venture, INOVYN

Solvay and INEOS announced the start-up of their Joint Venture INOVYN, a competitive player in chlorovinyls, following European Commission approval. The finalized terms of the Joint Venture agreement remain materially unchanged from those announced in June l2014. Solvay received upon closing an upfront cash payment of EUR 150 million - subject to customary adjustments such as actual working capital levels. In addition to contributing their entire European chlorovinyl business Solvay has transferred liabilities estimated at EUR 260 million into the Joint Venture. In three years' time, Solvay will exit INOVYN and receive an additional, performance-based payment targeted to be EUR 280 million, with a minimum of EUR 95 million. Thereafter, INEOS will be the sole owner of the business.

Solvay Presents at Credit Suisse Global Chemicals and Agriculture Conference 2015, Jun-23-2015

Solvay Presents at Credit Suisse Global Chemicals and Agriculture Conference 2015, Jun-23-2015 . Venue: 20 Columbus Courtyard, Canary Wharf, London, E14 4DA, United Kingdom.

Solvay Opens New Research and Innovation Laboratory in Tokyo

Solvay S.A. opened the Solvay Nicca Tokyo Innovation Laboratory, a new research and innovation laboratory, in Tokyo. Located near the Haneda airport and occupying a total area of 250 sqm, the laboratory will be the key innovation center for Solvay Novecare to support Japanese customers in the Agrochemical, Coatings, Home & Personal Care and Industrial markets. This laboratory is fundamental to the growth strategy of Solvay and represents an important milestone in its ambition to deliver sustainable and innovative technologies to its customers in Asia.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SOLB:BB €122.80 EUR -1.35

SOLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Asahi Kasei Corp ¥1,001 JPY -0.50
Celanese Corp $73.72 USD +1.72
Eastman Chemical Co $80.19 USD -0.86
Koninklijke DSM NV €52.61 EUR -0.34
Sealed Air Corp $51.87 USD -0.15
View Industry Companies

Industry Analysis


Industry Average

Valuation SOLB Industry Range
Price/Earnings 28.4x
Price/Sales 1.0x
Price/Book 1.5x
Price/Cash Flow 81.6x
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLVAY SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at